These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 9352601)
21. New immunosuppressive drugs in organ transplantation. Hughes SE; Gruber SA J Clin Pharmacol; 1996 Dec; 36(12):1081-92. PubMed ID: 9013363 [TBL] [Abstract][Full Text] [Related]
22. [Immunosuppressive long-term therapy of autoimmune diseases in hematology]. Nelius D; Stieglitz R Z Gesamte Inn Med; 1972 Jun; 27(11):480-3. PubMed ID: 4626749 [No Abstract] [Full Text] [Related]
23. [CD20 antibody for the treatment of systemic autoimmune diseases]. Tanaka Y Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437 [No Abstract] [Full Text] [Related]
24. [Cyclosporin in autoimmune diseases]. Follath F; Fontana A; Leumann E; Michel BA; Miescher PA; Schreier M; Schroeder M; Wenk M Schweiz Med Wochenschr; 1994 Jul; 124(27-28):1232-9. PubMed ID: 8052828 [TBL] [Abstract][Full Text] [Related]
25. Clinically validated approaches to the treatment of autoimmune diseases. Carter PH; Zhao Q Expert Opin Investig Drugs; 2010 Feb; 19(2):195-213. PubMed ID: 20050823 [TBL] [Abstract][Full Text] [Related]
26. Proliferation signal inhibitors for the treatment of refractory autoimmune rheumatic diseases: a new therapeutic option. Yoon KH Ann N Y Acad Sci; 2009 Sep; 1173():752-6. PubMed ID: 19758225 [TBL] [Abstract][Full Text] [Related]
27. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190 [No Abstract] [Full Text] [Related]
29. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases]. Szegedi G Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537 [TBL] [Abstract][Full Text] [Related]
30. Cyclosporine in the treatment of autoimmune disorders: a 10-year experience. Mitrovic D; Popovic M; Glisic B; Pavlica L; Dimitrijevic M Transplant Proc; 1998 Dec; 30(8):4134. PubMed ID: 9865324 [No Abstract] [Full Text] [Related]
31. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents]. Scheiffarth F; Warnatz H Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731 [No Abstract] [Full Text] [Related]
32. Commentary on new xenobiotic immunosuppressants for transplantation: Where are we, how did we get here, and where are we going? Morris RE Clin Transplant; 1993 Feb; 7(1 part 2):138-46. PubMed ID: 10148370 [No Abstract] [Full Text] [Related]
33. [Immunosuppressive drugs in systemic lupus erythematosus and rheumatoid arthritis]. Talpaz M Harefuah; 1980; 98(10):468-71. PubMed ID: 7450579 [No Abstract] [Full Text] [Related]
34. [Cyclosporin for the treatment of systemic autoimmune diseases]. Tanaka Y Nihon Rinsho; 2005 May; 63 Suppl 5():240-6. PubMed ID: 15954356 [No Abstract] [Full Text] [Related]
35. Immunosuppression in the era of biological agents. Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103 [TBL] [Abstract][Full Text] [Related]
37. The clinical use of immunosuppression. Watson DW; Johnson AG Med Clin North Am; 1969 Nov; 53(6):1225-41. PubMed ID: 4902918 [No Abstract] [Full Text] [Related]
38. [Mycophenolate mofetil in the treatment of selected connective tissue diseases]. Batko B; Krawiec P; Osieleniec J; Sułowicz W Przegl Lek; 2013; 70(9):724-9. PubMed ID: 24455833 [TBL] [Abstract][Full Text] [Related]
39. Immunosuppression and the rheumatic diseases. Denman AM Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):3-8. PubMed ID: 6978108 [TBL] [Abstract][Full Text] [Related]